Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

BACKGROUND: To evaluate the antitumour activity and safety of metronomic cyclophosphamide vs megestrol acetate in progressive and advanced cancer patients having exhausted all effective therapies under standard care. METHODS: Patients were randomly assigned to receive orally metronomic cyclophospham...

Descripción completa

Detalles Bibliográficos
Autores principales: Penel, N, Clisant, S, Dansin, E, Desauw, C, Dégardin, M, Mortier, L, Vanhuyse, M, Bonodeau, F, Fournier, C, Cazin, J-L, Adenis, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856003/
https://www.ncbi.nlm.nih.gov/pubmed/20354522
http://dx.doi.org/10.1038/sj.bjc.6605623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856003/
https://www.ncbi.nlm.nih.gov/pubmed/20354522
http://dx.doi.org/10.1038/sj.bjc.6605623

Ejemplares similares